Joint Inflammation News and Research

RSS
Exercise transiently suppresses inflammation in rheumatic disease

Exercise transiently suppresses inflammation in rheumatic disease

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust

Synthetic cannabinoid molecule created for osteoarthritis

Synthetic cannabinoid molecule created for osteoarthritis

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

Researchers link species of intestinal bacteria to onset of rheumatoid arthritis

Researchers link species of intestinal bacteria to onset of rheumatoid arthritis

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Delaying rheumatoid arthritis treatment could greatly increase likelihood of joint damage

Delaying rheumatoid arthritis treatment could greatly increase likelihood of joint damage

Anti-tumor necrosis factor drugs modestly reduce risk of acute coronary syndrome

Anti-tumor necrosis factor drugs modestly reduce risk of acute coronary syndrome

Two aggressive therapy approaches effective for children with juvenile idiopathic arthritis

Two aggressive therapy approaches effective for children with juvenile idiopathic arthritis

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Duke Medicine researchers identify a protein critical to TMJD pain

Duke Medicine researchers identify a protein critical to TMJD pain

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Scientists discover novel drug molecule that reduces swelling, inflammation in arthritic joints

Scientists discover novel drug molecule that reduces swelling, inflammation in arthritic joints

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis